Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis. Comment on: Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept.
Clin Exp Rheumatol
; 39(5): 1142-1143, 2021.
Article
em En
| MEDLINE
| ID: mdl-33666163
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Artrite Reumatoide
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Clin Exp Rheumatol
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Espanha